1Yamasaki S. TNM classificatian of liver cancer[J].Gan To Kagaku Ryoho,1997,24(9):1175-1182.
2Storniolo AM, Enas NH, Brown CA, et al. An investigational new drug treatment program for patients with genuitaline:results for over 3000 patients with pancreatic carcinoma[J]. Cancer,1999,85(6):1261-1268.
3Von-Hoff DD, Green MR. Gemcitabine HCl; Combined efficacy and tolerability in mangment the solid tumor patients[J]. Semin Oncol,1996,23(Suppl 10):1-10.
4Yang T, Lin Y, Chen J, et al. Phase Ⅱ study of gemcitabine in patients with advanced hepatocellular carcinoma[J].Cancer,2000,89(4): 750-756.
2[4]Chou F I,Fang K C,Chang C,et al.Lipiodol uptake and retention by human hepatoma cells[J].Nuc Med Biol,1995,22(3):379 ～ 386.
3[8]Wang S J,Lin W Y,Chen M N,et al.Biodistribution of rhenium- 188 lipiodol infused via the hepatic artery of rats with hepatic tumors [J].Europ Nucr Med,1996,23:13 ～ 17.
4[9]Madsen M T,Park C H,Takur M L.Dosimetry of iodine - 131ethiodol in the treatment of hepatoma [J].J Nucl Med,1988,29:1038 ～ 1044.
5杜进,金小海,陈大明,等.125I-碘化油的研制[J].同位素,1995,8(2):71-75.
6[11]Wang S J,Lin W Y,Chen M N,et al.Preparation and biodistribution of yttrium - 90 lipiodol in rats following hepatic arterial injection[J].Eur J Nucl Med,1995,22:233 ～ 236.
7[12]Wang S J,Lin W Y,Chen M N,et al.Radiolabeling of lipiodol with generator - produced 188 Re for hepatic tumor therap[J].Applied Radiation and Isotopes,1996,47:267 ～ 271.
8[13]YooHS,SuhJH,LeeJT,etal.Therapeutic feasibility study and clinical trial of intrahepatic I- 131 -lipiodol on patients with hepatocellular carcinoma [J].Korean J Nucl Med ,1986,20:61～71.
9[14]ParkCH,SuhJH,YooHS.EvaluationofintrahepaticI-131ethiodol on a patient with hepatocellular carcinoma [J].Clin Nucl Med ,1986,11:514～517.
10[15]KimYJ,JeongJM,ChangYS,etal.Preparation and biodistribution of Re - 188 sulfur colloid [J].Korean J Nucl Med,1998,32:298 ～ 304.
